ConductScience.org, home

Paper19902987

Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.

Zhou SF. Clin Pharmacokinet, 2009. Cited by 277 papers, by iCite.

Cite this record

ConductScience Library. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Papers, record 19902987. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19902987

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
PubMed
Journal
Clin Pharmacokinet
PubMed
Year
2009
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
277
iCite
Relative citation ratio, by iCite
9.68
iCite
Revised in PubMed
2022-04-08
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhou SFShu-Feng

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytochrome P-450 CYP2D6Major topic
Mental DisordersMajor topic
Polymorphism, GeneticMajor topic
Psychotropic DrugsMajor topic
Analgesics, Opioid
Animals
Antiemetics
Genotype
Histamine Antagonists
Humans
Muscarinic Antagonists
Phenotype
Selective Estrogen Receptor Modulators

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02624167A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic SchizophreniaBackground

Source ClinicalTrials.gov

Download CSV of trials

References453

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118382661Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample.PLoS One2008https://conductscience.org/library/papers/18382661PubMed
211907488Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19).Clin Pharmacol Ther2002https://conductscience.org/library/papers/11907488PubMed
31686692N(+)-glucuronidation of aliphatic tertiary amines, a general phenomenon in the metabolism of H1-antihistamines in humans.Xenobiotica1991https://conductscience.org/library/papers/1686692PubMed
418294088Latino versus Caucasian response to atomoxetine in attention-deficit/hyperactivity disorder.J Child Adolesc Psychopharmacol2008https://conductscience.org/library/papers/18294088PubMed
514717619Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.Drugs2004https://conductscience.org/library/papers/14717619PubMed
611133003CYP3A is responsible for N-dealkylation of haloperidol and bromperidol and oxidation of their reduced forms by human liver microsomes.Life Sci2000https://conductscience.org/library/papers/11133003PubMed
710982205Risperidone metabolism and the impact of being a cytochrome P450 2D6 ultrarapid metabolizer.J Clin Psychiatry2000https://conductscience.org/library/papers/10982205PubMed
817202571Safety of aripiprazole: high serum levels in a CYP2D6 mutated patient.Am J Psychiatry2007https://conductscience.org/library/papers/17202571PubMed
99143866Different effects of inhibitors on the O- and N-demethylation of codeine in human liver microsomes.Eur J Clin Pharmacol1997https://conductscience.org/library/papers/9143866PubMed
109352573Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence.Pharmacogenetics1997https://conductscience.org/library/papers/9352573PubMed
1115482390Population pharmacokinetic modelling of tramadol with application of the NPEM algorithms.J Clin Pharm Ther2004https://conductscience.org/library/papers/15482390PubMed
1217725248Lack of influence of CYP2D6 genotype on the clearance of (R)-, (S)- and racemic-methadone.Int J Clin Pharmacol Ther2007https://conductscience.org/library/papers/17725248PubMed
1313773933Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine.JAMA1961https://conductscience.org/library/papers/13773933PubMed
148093319Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine.Lancet1993https://conductscience.org/library/papers/8093319PubMed
1515168101Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting.Eur J Clin Pharmacol2004https://conductscience.org/library/papers/15168101PubMed
166120818Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes.Drug Metab Dispos1981https://conductscience.org/library/papers/6120818PubMed
17321205Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.Drugs1977https://conductscience.org/library/papers/321205PubMed
1816236141Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine.Basic Clin Pharmacol Toxicol2005https://conductscience.org/library/papers/16236141PubMed
1915987423Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients.Breast Cancer Res2005https://conductscience.org/library/papers/15987423PubMed
208013282The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.Drug Metab Dispos1994https://conductscience.org/library/papers/8013282PubMed

See all 453 referencesDownload CSV of references

Cited by137

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 277 citations.

PMIDTitleJournalYearIn PapersSource
42792193CYP2D6 as an Emerging Endogenous Oxidative Stress Modulator in Cardiovascular Disease: Genetic, Pharmacological, and Redox Perspectives.Antioxidants (Basel)2026https://conductscience.org/library/papers/42792193PubMed
42291620Investigation of Pharmacogenomic Variants in the CYP (P450) Family in Native American Populations of the Brazilian Amazon.Int J Genomics2026https://conductscience.org/library/papers/42291620PubMed
41816596A nine-gene nicotine-metabolism signature predicts prognosis and characterizes the immune landscape in colon adenocarcinoma.J Gastrointest Oncol2026https://conductscience.org/library/papers/41816596PubMed
41460788Development of a CYP2D6-enhanced HepaRG cell model with improved CYP2D6 metabolic capacity.PLoS One2025https://conductscience.org/library/papers/41460788PubMed
40847116The impact of the number of non-opioid psychotropic medications and their co-exposures during pregnancy on short-term outcomes in full-term neonates.Sci Rep2025https://conductscience.org/library/papers/40847116PubMed
40191458In silico approaches to identify novel anti-diabetic type 2 agents against dipeptidyl peptidase IV from isoxazole derivatives of usnic acid.3 Biotech2025https://conductscience.org/library/papers/40191458PubMed
40188031The augmentative efficacy of second-generation anti-psychotics (SGA) to anti-depressants in treating treatment-resistant depression: a network meta-regression analysis.BMC Psychiatry2025https://conductscience.org/library/papers/40188031PubMed
40006546
Physiologically Based Pharmacokinetic Model of CYP2D6 Associated Interaction Between Venlafaxine and Strong Inhibitor Bupropion-The Influence of Age-Relevant Changes and Inhibitory Dose to Classify Therapeutical Success and Harm.
Pharmaceutics2025https://conductscience.org/library/papers/40006546PubMed
39899439CYP2D6 genotype and associated 5-HT3 receptor antagonist outcomes: A systematic review and meta-analysis.Clin Transl Sci2025https://conductscience.org/library/papers/39899439PubMed
39832962
Effect of a multimodal analgesia strategy on remifentanil daily consumption in mechanically ventilated adult ICU patients: study protocol for a randomised, placebo-controlled, double-blind, parallel-group clinical trial.
BMJ Open2025https://conductscience.org/library/papers/39832962PubMed
39774017High-coverage whole-genome sequencing of a Jakun individual from the "Orang Asli" Proto-Malay subtribe from Peninsular Malaysia.Hum Genome Var2025https://conductscience.org/library/papers/39774017PubMed
39469676Estrogenic post-menopausal anti-osteoporotic mechanism of Achyranthes aspera L.: Phytochemicals and network pharmacology approaches.Heliyon2024https://conductscience.org/library/papers/39469676PubMed
39201627Pharmacogenetic Approach to Tramadol Use in the Arab Population.Int J Mol Sci2024https://conductscience.org/library/papers/39201627PubMed
38797832Association of CYP2D6 and CYP2C19 metabolizer status with switching and discontinuing antidepressant drugs: an exploratory study.BMC Psychiatry2024https://conductscience.org/library/papers/38797832PubMed
38765225An Effective Method to Facilitate Personalized and Precise Medicine for Schizophrenia Treatment Based on Pharmacogenomics.Psychiatry Clin Psychopharmacol2021https://conductscience.org/library/papers/38765225PubMed
37993281Genotype-guided new approach for dose optimisation of hydroxychloroquine administration in Chinese patients with SLE.Lupus Sci Med2023https://conductscience.org/library/papers/37993281PubMed
37719112Effect of apatinib on the pharmacokinetics of tramadol and O-desmethyltramadol in rats.PeerJ2023https://conductscience.org/library/papers/37719112PubMed
37670118Multivariate QSAR, similarity search and ADMET studies based in a set of methylamine derivatives described as dopamine transporter inhibitors.Mol Divers2024https://conductscience.org/library/papers/37670118PubMed
37568345How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?J Clin Med2023https://conductscience.org/library/papers/37568345PubMed
37554850Tramadol poisoning and its management and complications: a scoping review.Ann Med Surg (Lond)2023https://conductscience.org/library/papers/37554850PubMed

See all 137 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP2D61565PubTator's text mininghttps://conductscience.org/library/genes/1565

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19902987

GET https://conductscience.org/api/papers/v1/19902987/references?page=2